Outcome of endometrial carcinoma patients with involvement of the uterine serosa

Gynecologic Oncology

Volumn 82, Issue 2, 2001, Pages 338-343

  Ashman, Jonathan B ^a   Connell, Philip P ^a   Yamada, Diane ^a   Rotmensch, Jacob ^a   Waggoner, Steve E ^a   Mundt, Arno J ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Endometrial cancer; Radiation therapy; Uterine serosa

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEROSA; TREATMENT OUTCOME;

EID: 0034909214     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6189     Document Type: Article

References (37)

1. FIGO stages - 1988 Revision
2. Pathological models to predict outcome for women with endometrial adenocarcinoma: The importance of the distinction between surgical stage and clinical stage - A Gynecologic Oncology Group study
3. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients
4. Benefit of external irradiation in pathologic stage I endometrial carcinoma: A prospective clinical trial of 605 patients who received postoperative vaginal irradiation and additional pelvic irradiation in the presence of unfavorable prognostic factors
5. Analysis of failure patterns in stage III endometrial carcinoma and therapeutic implications
6. Ovarian metastasis in endometrial carcinoma
7. The significance of adnexal involvement in endometrial carcinoma
8. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study
9. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: Analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy
10. Adenocarcinoma of the endometrium: Survival comparisons of patients with and without pelvic node sampling
11. Peritoneal washing cytology in gynecologic cancers: Long-term follow-up of 355 patients
12. Experience with pelvic washings with stage I and II endometrial carcinoma
13. The justification of a surgical staging system in endometrial carcinoma
14. Endometrial cancer: Prognostic factors
15. The prognostic significance of vascular invasion by endometrial carcinoma
16. Treatment of intraperitoneal metastatic adeno-carcinoma of the endometrium by the whole-abdomen moving-strip technique and pelvic boost irradiation
17. Abdominal radiotherapy for cancer of the uterine cervix and endometrium
18. Adjuvant whole abdominopelvic irradiation for high risk endometrial carcinoma
19. Chemotherapy as adjuvant and salvage treatment in women with endometrial carcinoma
20. Adjuvant chemotherapy for high-risk endometrial cancer
21. A phase I study of weekly cisplatin and whole abdominal radiation for the treatment of stage III and IV endometrial carcinoma: A Gynecologic Oncology Group pilot study
22. Nonparamatric estimation from incomplete observations
23. Evaluation of survival data and two new rank order statistics arising in its consideration
24. Pathologic stage III endometrial carcinoma
25. Prognostic factors in surgical stage III and IV carcinoma of the endometrium
26. Prognostic factors relating to survival in uterine endometrioid carcinoma
27. The effect of postsurgical therapy on stage III endometrial carcinoma
28. Clinical stage I endometrial cancer: Prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system
29. Prognostic factors and long-term survival in endometrial adenocarcinoma with cervical involvement
30. Race and clinical outcome in endometrial carcinoma
31. External pelvic radiation therapy in stage IC endometrial carcinoma
32. Pelvic control following external beam radiation for surgical stage I endometrial adenocarcinoma
33. A prospective trial of postoperative vaginal radium/cesium for grade I-II less than 50% myometrial invasion and pelvic radiation therapy for grade 3 or deep myometrial invasion in surgical stage I endometrial adenocarcinoma
34. Prognostic significance of positive peritoneal cytology in clinical stage I adenocarcinoma of the endometrium
35. Surgery and postoperative radiation therapy in stage II endometrial cancer
36. Survival of women with surgical stage II endometrial cancer